BioSpace News Archive

Meridian Bioscience, Inc. announced today that its inhibitor-tolerant qPCR master mixes are ideal for the development of fast, accurate and highly sensitive qPCR monkeypox virus (monkeypox) molecular diagnostic tests.

VectorY Therapeutics, a biotech company focusing on the development of innovative gene therapy approaches for the treatment of muscular and neurodegenerative disorders through vectorized antibodies, today announces presentation of a poster at the European Network to Cure ALS (ENCALS) Annual Meeting at the University of Edinburgh on 1-3 June, 2022.

New Study from Seraphina Therapeutics Finds that a Good Saturated Fat, C15:0, is Better, Broader and Safer than Omega-3.

Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual and special meeting of shareholders held on May 26, 2022 (the “Meeting”), which included the election as directors of the Company of all of the nominees listed in its management information and proxy circular dated April 14, 2022 (the “Information Circular”).

4WEB Medical announced that the company achieved record revenue in Q1 2022, largely driven by sales of the company’s stand alone devices for ALIF and ACDF procedures.

Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will be participating in the upcoming William Blair Growth Stock Conference in Chicago.

Y-mAbs Therapeutics, Inc. announced that Dr. Shakeel Modak, MD from Memorial Sloan Kettering will present results from the naxitamab-based chemoimmunotherapy trial in patients with chemoresistant high-risk neuroblastoma, at the American Society of Clinical Oncology Annual Meeting to be held June 3-7, 2022.

Albany NY, United States: Medical imaging in orthopedics helps physicians to non-invasively analyze the body’s internal anatomy to aid in diagnosing a medical condition.

Albany NY, United States: An increase in the funding activities in the biotechnology sector coupled with the latest advancements in biological and chemical research will bring immense growth prospects for the laboratory supplies market during the forecast period of 2021-2031.

LumiraDx Limited, a next-generation point of care diagnostics company, announced its HbA1c test has achieved CE Marking.